FilingSEC EDGAR8-K
Anavex Life Sciences Regains Nasdaq Listing Compliance
· SEC accepted
StageCompliance Regained
Filing content
The company announced that it has regained compliance with Nasdaq listing rules following the filing of its overdue quarterly reports.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…